These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18202325)

  • 1. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway.
    Pamuklar Z; Lee JS; Cheng HY; Panchatcharam M; Steinhubl S; Morris AJ; Charnigo R; Smyth SS
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):555-61. PubMed ID: 18202325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
    Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
    Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
    Sandmann G; Siess W; Essler M
    Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline.
    Nilsson U; Svensson SP; Grenegård M
    Haematologica; 2002 Jul; 87(7):730-9; discussion 739. PubMed ID: 12091124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombogenic and atherogenic activities of lysophosphatidic acid.
    Siess W; Tigyi G
    J Cell Biochem; 2004 Aug; 92(6):1086-94. PubMed ID: 15258894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate.
    Motohashi K; Shibata S; Ozaki Y; Yatomi Y; Igarashi Y
    FEBS Lett; 2000 Feb; 468(2-3):189-93. PubMed ID: 10692584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of lysophosphatidic acid on platelet protein phosphorylation.
    Gerrard JM; Beattie LL; McCrae JM; Singhroy S
    Biochem Cell Biol; 1987 Jul; 65(7):642-50. PubMed ID: 3435662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective non-lipid modulator of LPA5 activity in human platelets.
    Kozian DH; Evers A; Florian P; Wonerow P; Joho S; Nazare M
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5239-43. PubMed ID: 22801643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity.
    Smyth SS; Sciorra VA; Sigal YJ; Pamuklar Z; Wang Z; Xu Y; Prestwich GD; Morris AJ
    J Biol Chem; 2003 Oct; 278(44):43214-23. PubMed ID: 12909631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques.
    Khandoga AL; Pandey D; Welsch U; Brandl R; Siess W
    Cardiovasc Res; 2011 Apr; 90(1):157-64. PubMed ID: 21106562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration.
    Ward Y; Lake R; Faraji F; Sperger J; Martin P; Gilliard C; Ku KP; Rodems T; Niles D; Tillman H; Yin J; Hunter K; Sowalsky AG; Lang J; Kelly K
    Cell Rep; 2018 Apr; 23(3):808-822. PubMed ID: 29669286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion of human platelets to albumin is synergistically increased by lysophosphatidic acid and adrenaline in a donor-dependent fashion.
    Eriksson AC; Whiss PA; Nilsson UK
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):359-68. PubMed ID: 16788312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid presynaptically blocks NO uptake during electric field stimulation-induced relaxation via LPA(1) receptor in cat lower esophageal sphincter.
    Lee JW; Kim CH; Wang YY; Yan XM; Sohn UD
    Arch Pharm Res; 2011 Jan; 34(1):169-76. PubMed ID: 21468929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation.
    Pandey D; Goyal P; Siess W
    Blood Cells Mol Dis; 2007; 38(3):269-79. PubMed ID: 17321765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
    Siess W
    Biochim Biophys Acta; 2002 May; 1582(1-3):204-15. PubMed ID: 12069830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation.
    Gerrard JM; Robinson P; Narvey M; McNicol A
    Biochem Cell Biol; 1993; 71(9-10):432-9. PubMed ID: 8192895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.